Blueprint Medicines
BPMC
$108.55
Share price
2.16%
Change (1 day)
98.45%
Change (1 year)
Categories
Blueprint Medicines (BPMC) Fails to deliver data
Key failure to deliver metrics for Blueprint Medicines :
- Last SEC data release: 2024-04-12
- Last 15 days FTD volume: $0.49 M
- Last 3 months FTD volume: $5.79 M
- Last year FTD volume: $31.43 M
Failures to deliver for Blueprint Medicines (BPMC) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Blueprint Medicines (BPMC) - since 2015
Volume in USD (price x number of shares), data since 2015Blueprint Medicines (BPMC) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $6.85 M | -75.94% |
| 2023 | $28.47 M | 80.82% |
| 2022 | $15.74 M | 142.95% |
| 2021 | $6.48 M | -76.68% |
| 2020 | $27.8 M | 97.68% |
| 2019 | $14.06 M | -86.59% |
| 2018 | $0.10 B | 464.44% |
| 2017 | $18.57 M | 224.4% |
| 2016 | $5.72 M | -44.11% |
| 2015 | $10.24 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pacific Biosciences
PACB | $14.64 M | $18 M | 🇺🇸 USA |
 OPKO Health
OPK | $40.6 M | $49.01 M | 🇺🇸 USA |
 Isoray
ISR | $0.01 M | $0.18 M | 🇺🇸 USA |